Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach.
Letter to the Editor: Trigeminal neuralgia in patients with multiple sclerosis.
Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
The effectiveness of a self-management occupational therapy intervention on activity performance in individuals with multiple sclerosis-related fatigue: a randomized-controlled trial.
Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment.
Gray matter imaging in multiple sclerosis: what have we learned?
Is progressive multiple sclerosis a gray matter disease?
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.
Disappearing MS T2 lesions may have persistent tissue injury by diffusion tensor and magnetisation transfer imaging
The Characteristics of Multiple Sclerosis in Iran.
MRI as an outcome in multiple sclerosis clinical trials.
Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells.
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.
Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
MRI in multiple sclerosis: what's inside the toolbox?
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach.
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Epidemiology of Multiple Sclerosis in Latin America: Critical Analysis of the Literature.
Disability as an outcome in MS clinical trials.
MRI monitoring of spinal cord changes in patients with multiple sclerosis.
Multiple sclerosis: Real-world long-term benefits of disease-modifying MS therapy.
Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patients.
Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.
Treating multiple sclerosis with monoclonal antibodies: a 2010 update.
Manual Segmentation of MS Cortical Lesions Using MRI: A Comparison of 3 MRI Reading Protocols.
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »